V2X, Inc. (VVX): Operating Cash Flow
$181.99M
Year ended 2025-12-31
$140.56M
Trailing 12 months to 2026-07-03
+24.9%
3-year compound annual growth
+23.2%
5-year compound annual growth
+25.4%
10-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $181.99M | -28.4% | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | $254.24M | +35.3% | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | $187.97M | +101.0% | 2026-02-23, From 2023-01-01 |
| 2022-12-31 | $93.50M | +52.4% | 2025-02-24, From 2022-01-01 |
| 2021-12-31 | $61.34M | -4.3% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | $64.08M | +132.5% | 2023-03-02, From 2020-01-01 |
| 2019-12-31 | $27.56M | -31.2% | 2022-03-07, From 2019-01-01 |
| 2018-12-31 | $40.06M | +13.1% | 2021-03-02, From 2018-01-01 |
| 2017-12-31 | $35.41M | -3.3% | 2020-03-03, From 2017-01-01 |
| 2016-12-31 | $36.62M | +94.0% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $18.88M | -56.1% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $42.98M | -53.7% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $92.79M | -19.9% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $115.87M | n/a | 2015-03-16, From 2012-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| V2X, Inc. (VVX) | 2025-12-31 | $181.99M | -28.4% |
| Genpact Ltd (G) | 2025-12-31 | $812.86M | +32.1% |
| FTI Consulting, Inc (FCN) | 2025-12-31 | $152.13M | -61.5% |
| Astrana Health, Inc. (ASTH) | 2025-12-31 | $114.60M | +119.5% |
| Gartner Inc (IT) | 2025-12-31 | $1.29B | -13.1% |
| Evolent Health, Inc. (EVH) | 2025-12-31 | $38.84M | +107.0% |
| ICF International, Inc. (ICFI) | 2025-12-31 | $141.87M | -17.3% |
| Booz Allen Hamilton Holding Corp (BAH) | 2026-03-31 | $1.04B | +3.2% |
| Huron Consulting Group Inc. (HURN) | 2025-12-31 | $193.39M | -3.9% |
Compare VVX, G, FCN, ASTH side by side · Screen every company in Services-Facilities Support Management Services ↗